Mexico Homeopathy Products Market
市场规模（十亿美元）
CAGR :
% 
USD
162.29 Million
USD
400.53 Million
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 162.29 Million |
 Market Size (Forecast Year) |
USD 400.53 Million |
 CAGR |
% |
| Major Markets Players |
|
墨西哥順勢療法產品市場細分，按產品類型（稀釋液、片劑、酊劑、軟膏、生物化學品、油和其他）、治療（古典順勢療法、臨床順勢療法、複雜順勢療法和其他）、來源（植物、礦物質和動物）、應用（鎮痛和解熱、呼吸系統疾病、免疫系統疾病、胃腸病、神經系統疾病、皮膚神經系統(CNS)、精神健康、荷爾蒙疾病、性健康、肥胖、眼科疾病和其他）、給藥途徑（口服產品、外用產品和其他）、購買方式（非處方 (OTC) 和處方藥）、年齡組（成人、老年人和兒童）、性別（男性和女性）、最終用戶（順勢療法中心、診所、醫院、家庭護理和其他趨勢
順勢療法產品市場規模
- 2024 年墨西哥順勢療法產品市場價值為1.6229 億美元，預計到 2032 年將達到 4.0053 億美元
- 在 2025 年至 2032 年的預測期內，市場可能會以12.0% 的複合年增長率成長，主要原因是消費者對自然健康解決方案的認識不斷提高
- 這一增長是由慢性病患病率上升等因素推動的。此外，價格實惠也推動了順勢療法作為醫療保健解決方案的日益普及。
順勢療法產品市場分析
- 由於消費者對天然和替代療法的偏好日益增長，墨西哥順勢療法產品市場正在穩步增長。許多人尋求順勢療法來治療慢性病、輕微疾病以及整體健康，這推動了對本地和國際製造商產品的需求。人們對整體健康方法的認識日益增強，進一步推動了這一趨勢。
- 然而，監管挑戰給市場參與者帶來了挑戰。墨西哥的順勢療法產品必須符合藥品法規，包括嚴格的標籤、安全評估和批准。這可能會造成進入壁壘，尤其是對外國品牌而言，從而延遲產品上市並增加合規成本。儘管消費者接受度較高，但監管審查仍是一項關鍵挑戰。
- 例如，2022年，威爾瑪·施瓦貝有限公司（Dr. Willmar Schwabe GmbH & Co. KG）的子公司Schwabe México因監管要求的不斷變化，導致其推出新的順勢療法產品線出現延誤。該公司不得不修改包裝和文件，以符合墨西哥的藥品合規標準，這導致其市場准入被推遲，並增加了成本。
報告範圍和順勢療法產品市場細分
|
屬性 |
順勢療法產品關鍵市場洞察 |
|
涵蓋的領域 |
|
|
覆蓋國家 |
墨西哥 |
|
主要市場參與者 |
|
|
市場機會 |
|
|
加值資料資訊集 |
除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。 |
順勢療法產品市場趨勢
“數位化順勢療法解決方案的採用率不斷提高”
- 墨西哥順勢療法產品市場的一個突出趨勢是數位化順勢療法解決方案的採用日益增多
- 這些先進的平台透過提供即時症狀追蹤、個人化治療建議和自動劑量調整來增強治療管理，從而提高治療精準度和整體健康結果
- 例如，人工智慧驅動的順勢療法應用程式與患者健康數據相結合，分析症狀並提出針對性的治療方法，減少了手動追蹤的需要並確保最佳治療效果。
- 數位平台還促進了無縫數據共享，使患者和醫生能夠監測進展、改進治療並預防併發症
- 這一趨勢正在改變順勢療法，提高患者的依從性和治療效果，並推動市場對創新順勢療法解決方案的需求
順勢療法產品市場動態
司機
“提高消費者對自然健康解決方案的認識”
- 隨著越來越多的消費者尋求傳統藥物治療的替代品，對順勢療法的需求也隨之增加
- 這種轉變是由不斷上漲的醫療成本、對藥物副作用的擔憂以及對整體健康的更廣泛的文化興趣所推動的
- 隨著消費者對順勢療法等自然療法的益處有了更多的了解，他們越來越多地選擇那些被認為更安全、更永續的長期健康管理解決方案
- 此外，網路和社群媒體在提高人們的認識和更容易獲得有關順勢療法產品的好處和可用性的資訊方面發揮著關鍵作用
例如，
- 2024年1月，根據加州自治大學（UABC）發表的文章，這篇文章探討了包括順勢療法在內的傳統醫學如何融入墨西哥醫療保健體系。文章強調，儘管主流醫學界對替代療法的科學驗證和有效性仍存在爭議，但受消費者對整體、便捷治療的需求推動，替代療法在墨西哥的文化相關性和日益增長的接受度仍在提升。
- 消費者對天然健康替代品的認知度不斷提升，順勢療法市場也因此受益。這一趨勢，加上傳統醫療成本的上漲，正促使人們更多地接受順勢療法。然而，諸如科學懷疑論和監管問題等挑戰依然存在。如果透過教育和改進標準化來消除這些障礙，墨西哥的順勢療法市場有望實現顯著增長，而推動力在於日益注重健康且知情的消費者群體，他們正在尋求比傳統醫療療法更安全、更實惠的替代品。
機會
“政府倡導順勢療法”
- 在墨西哥，政府對順勢療法的認可度和監管力度不斷加大，為從業者和製造商創造了更規範的環境，從而增強了消費者的信任
- 隨著人們對順勢療法的認識不斷提高，越來越多的人開始尋求替代療法來改善健康和保健，這推動了對順勢療法藥物的需求
- 教育措施有助於傳播有關這些產品的好處和用途的信息，從而促進普通民眾更廣泛地接受這些產品
例如，
- 根據順勢療法健康診所於2024年3月發表的一篇文章，墨西哥政府支持順勢療法，並開設了順勢療法大學學位課程。這個教育框架提升了順勢療法作為合法醫療實踐的可信度，並促進了順勢療法研發的進步，確保順勢療法對民眾安全有效。
- 2022年2月，據拉丁新聞社（Prensa Latina）發表的一篇文章稱，墨西哥國立理工學院（IPN）和墨西哥國立自治大學（UNAM）支持使用順勢療法作為針對新冠肺炎的個體化治療。
- 政府推動順勢療法領域研發的措施可以提升產品品質和創新。透過提供資金和資源，政府可以支持本地生產和分銷，使順勢療法產品更容易被消費者接受。這種方法使墨西哥能夠同時受益於本地和全球市場，充分利用人們對整體和自然健康解決方案日益增長的興趣，同時可能開闢通往國際市場的出口管道。
克制/挑戰
“缺乏科學證據”
- 與基於嚴格臨床試驗和實證數據的傳統醫學不同，順勢療法通常缺乏一致的科學驗證。許多支持順勢療法的研究因方法學缺陷而受到批評，例如樣本量小和對照不足。此外，配方缺乏標準化，這意味著不同的醫生可能會開出不同的劑量或藥物，導致結果不一致。缺乏科學嚴謹性和標準化實踐，損害了順勢療法作為合法醫療保健解決方案的可信度。
例如，
- 根據AME出版公司於2021年6月發表的文章，該文章回顧了順勢療法的歷史應用以及關於其療效的持續爭論。在墨西哥，人們對順勢療法作為替代療法的興趣日益濃厚，這反映了尋求自然療法的普遍趨勢。然而，由於缺乏強有力的臨床證據，順勢療法的廣泛接受度面臨挑戰，這不僅影響了消費者的信任，也影響了監管審查。
- 2023年7月，NCBI的一篇文章重點介紹了順勢療法的科學證據，特別是其在治療慢性疾病和病症方面的應用。文章探討了透過常規臨床試驗證明順勢療法療效的挑戰，並回應了積極的發現和質疑。該綜述呼籲進行更多高品質、大規模的研究，以更好地評估順勢療法作為合法治療方案的潛力。
- 2024年5月，NCBI報告稱，該文章進一步證明了高水準的科學證據支持順勢療法的成本效益。這項發現強調了進一步研究和標準化的必要性，為解決人們對順勢療法實踐的科學證據和一致性的擔憂奠定了基礎。
- 缺乏科學證據和標準化仍然是順勢療法推廣應用的重大障礙。由於缺乏紮實的研究和標準化的實踐，順勢療法在醫學界仍面臨質疑，難以廣泛認可。為了克服這項挑戰，需要進行更嚴格、更大規模的研究，並建立清晰的監管框架，以確保順勢療法的安全性和有效性。
順勢療法產品市場範圍
市場根據類型、治療、來源、應用、給藥途徑、購買方式、年齡層、性別、最終用戶和分銷管道進行細分。
|
分割 |
細分 |
|
依產品類型 |
|
|
按治療 |
|
|
按來源 |
|
|
按應用 |
|
|
依給藥途徑 |
|
|
按購買方式 |
|
|
按年齡組
|
|
|
按性別 |
|
|
按最終用戶 |
|
|
按分銷管道 |
|
順勢療法產品市場佔有率
市場競爭格局按競爭對手提供詳細資料。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投入、新市場計劃、國家/地區分佈、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度以及應用主導地位。以上提供的數據點僅與公司在市場中的重點相關。
市場中主要的市場領導者有：
- Schwabe México, SA de CV (Dr. Willmar Schwabe GmbH & Co. KG)（德國）
- Biologische Heilmittel Heel GmbH（德國）
- NARTEX 實驗室（墨西哥）
- AF Operadora de Negocios SA de CV（墨西哥）
- 墨西哥天然有機農場，SA de CV（墨西哥）
- Similia（墨西哥）
- Sinergia Farmacéutica SAPI de CV (Biofarma Natural CMD SA de CV)（墨西哥）
- Häsler 順勢療法實驗室（墨西哥）
- Botanic Healthcare（印度）
墨西哥順勢療法產品市場的最新發展
- 2025年3月，Schwabe集團收購了Braineffect的多數股權，鞏固了在功能性食品和補充劑市場的地位。執行長Olaf Schwabe強調了該品牌的創新性，以及其與Schwabe健康生活使命的契合度。創辦人Fabian Foelsch將繼續留任。這項策略措施旨在重新定義數位時代的健康，擴大Schwabe的影響力和覆蓋範圍。
- 2024年4月，一項臨床試驗證實了專利薰衣草油製劑Silexan對治療輕度至中度憂鬱症的有效性。在一項為期8週、納入498名患者的研究中，Silexan表現出顯著的抗憂鬱效果，與舍曲林相當。這些結果凸顯了其作為天然治療方案的潛力。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MEXICO HOMEOPATHY PRODUCTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 DBMR TRIPOD DATA VALIDATION MODEL
2.4 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.5 MEXICO HOMEOPATHY PRODUCTS MARKET: MULTIVARIATE MODELLING
2.6 DBMR MARKET POSITION GRID
2.7 MARKET END USER COVERAGE GRID
2.8 VENDOR SHARE ANALYSIS
2.9 SECONDARY SOURCES
2.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 CUSTOMER BEHAVIOR ANALYSIS: MEXICO HOMEOPATHY PRODUCTS MARKET
4.4 EPIDEMIOLOGY: MEXICO HOMEOPATHY PRODUCTS MARKET
4.5 HOMEOPATHY ADOPTION IN MEXICO
4.6 DRUG TREATMENT RATE BY MATURED MARKETS: MEXICO HOMEOPATHY PRODUCTS MARKET
4.7 KEY PRICING STRATEGIES: MEXICO HOMEOPATHY PRODUCTS MARKET
4.8 TOP 10 BEST-SELLING HOMEOPATHY PRODUCTS IN THE MEXICO MARKET
5 MEXICO HOMEOPATHY PRODUCTS MARKET, REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING CONSUMER AWARENESS OF NATURAL HEALTH SOLUTIONS
6.1.2 RISING PREVALENCE OF CHRONIC DISEASES
6.1.3 AFFORDABILITY DRIVES GROWING ADOPTION OF HOMEOPATHIC REMEDIES AS A HEALTHCARE SOLUTION
6.2 RESTRAINTS
6.2.1 LACK OF SCIENTIFIC EVIDENCE
6.2.2 INEFFECTIVENESS IN TREATING LIFE-THREATENING INFECTIONS
6.3 OPPORTUNITIES
6.3.1 ADVOCACY BY GOVERNMENT FOR HOMEOPATHY
6.3.2 AVAILABILITY OF HOMEOPATHY MEDICINES IN E-COMMERCE
6.3.3 UTILIZING HOMEOPATHY AS AN ADJUNCT TREATMENT
6.4 CHALLENGES
6.4.1 DELAYED THERAPEUTIC RESPONSE OF HOMEOPATHIC MEDICINES
6.4.2 REGULATORY AND LEGAL ISSUES
7 MEXICO HOMEOPATHY PRODUCTS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 DILUTIONS
7.2.1 BY POTENCY
7.2.1.1 HIGH POTENCY
7.2.1.1.1 50M
7.2.1.1.2 CM (CENTESIMAL)
7.2.1.2 MEDIUM POTENCY
7.2.1.2.1 10M
7.2.1.2.2 1M
7.2.1.2.3 200C
7.2.1.2.4 30C
7.2.1.3 LOW POTENCY
7.2.1.3.1 LM (50 MILLESIMAL)
7.2.1.3.2 30X
7.2.1.3.3 12X
7.2.1.3.4 6X
7.2.2 BY SOURCE
7.2.2.1 PLANTS
7.2.2.1.1 HERBS
7.2.2.1.2 FLOWERS
7.2.2.1.3 TREES
7.2.2.2 MINERALS
7.2.2.2.1 NON-METALLIC MINERALS
7.2.2.2.1.1 CALCAREA CARBONICA (CALCIUM CARBONATE)
7.2.2.2.1.2 SILICEA (SILICA)
7.2.2.2.1.3 OTHERS
7.2.2.2.2 METALLIC MINERALS
7.2.2.2.2.1 AURUM METALLICUM (GOLD)
7.2.2.2.2.2 FERRUM METALLICUM (IRON)
7.2.2.2.2.3 OTHERS
7.2.2.3 ANIMALS
7.2.2.3.1 APIS MELLIFICA (HONEYBEE)
7.2.2.3.2 LACHESIS MUTA (BUSHMASTER SNAKE)
7.2.2.3.3 OTHERS
7.3 TABLETS
7.3.1 SUGAR-BASED TABLETS
7.3.2 PILLULES AND PELLETS
7.3.3 LACTOSE-FREE TABLETS
7.3.4 ORALLY DISINTEGRATING TABLETS (ODTS)
7.3.5 OTHERS
7.4 TINCTURE
7.4.1 BY PRODUCT TYPE
7.4.1.1 ARNICA
7.4.1.2 ECHINACEA
7.4.1.3 TURMERIC
7.4.1.4 ELDERBERRY
7.4.1.5 PROPOLIS
7.4.1.6 HYPERICUM PERFORATUM
7.4.1.7 ACONITUM
7.4.1.8 HEPAR SULPHURIS CALCAREUM
7.4.1.9 STAPHYSAGRIA
7.4.1.10 BENZOIN
7.4.1.11 IODINE
7.4.1.12 CANNABIS
7.4.1.13 OTHERS
7.4.2 BY TYPE,
7.4.2.1 ROOTS
7.4.2.2 LEAF
7.4.2.3 FLOWER
7.4.2.4 OTHERS
7.4.3 BY SOURCE
7.4.3.1 PLANTS
7.4.3.1.1 CANNABIS
7.4.3.1.2 CHAMOMILE
7.4.3.1.3 GINGKO
7.4.3.1.4 GINGER
7.4.3.1.5 VALERIAN
7.4.3.1.6 GARLIC
7.4.3.1.7 FEVERFEW
7.4.3.1.8 MILK THISTLE
7.4.3.1.9 GINSENG
7.4.3.1.10 SAW PALMETTO
7.4.3.1.11 OTHERS
7.4.3.2 MINERALS
7.4.3.3 ANIMALS
7.5 OINTMENTS
7.5.1 BY SIZE
7.5.1.1 30 GM
7.5.1.2 60 GM
7.5.1.3 25 GM
7.5.1.4 75 GM
7.5.1.5 OTHERS
7.5.2 BY USAGE
7.5.2.1 TOPICAL PAIN RELIEF
7.5.2.1.1 MUSCLE PAIN
7.5.2.1.2 ARTHRITIS
7.5.2.1.3 JOINT PAIN
7.5.2.1.4 PILES & FISSURES
7.5.2.1.5 INSECT BITES & HIVES
7.5.2.1.6 OTHERS
7.5.2.2 SKIN CONDITIONS
7.5.2.2.1 PSORIASIS
7.5.2.2.2 ECZEMA
7.5.2.2.3 ACNE
7.5.2.2.4 OTHERS
7.5.2.3 SCAR HEALING
7.5.2.4 BURN AND WOUND CARE
7.5.2.5 OTHERS
7.6 BIOCHEMICS
7.6.1 PLANTS
7.6.2 MINERALS
7.6.3 ANIMALS
7.7 OILS
7.7.1 ARNICA OIL
7.7.2 CALENDULA OIL
7.7.3 HYPERICUM OIL
7.7.4 RHUS TOXICODENDRON OIL
7.7.5 BELLADONNA OIL
7.7.6 LAVENDER OIL
7.7.7 CHAMOMILE OIL
7.7.8 MENTHOLATED OIL
7.7.9 EUCALYPTUS OIL
7.7.10 OTHERS
7.8 OTHERS
8 MEXICO HOMEOPATHY PRODUCTS MARKET, BY AGE GROUP
8.1 OVERVIEW
8.2 ADULTS
8.3 GERIATRIC
8.4 PEDIATRIC
9 MEXICO HOMEOPATHY PRODUCTS MARKET, BY GENDER
9.1 OVERVIEW
9.2 MEN
9.3 WOMEN
10 MEXICO HOMEOPATHY PRODUCTS MARKET, BY TREATMENT
10.1 OVERVIEW
10.2 CLASSICAL HOMEOPATHY
10.3 CLINICAL HOMEOPATHY
10.4 COMPLEX HOMEOPATHY
10.5 OTHERS
11 MEXICO HOMEOPATHY PRODUCTS MARKET, BY SOURCE
11.1 OVERVIEW
11.2 PLANTS
11.2.1 CANNABIS
11.2.2 CHAMOMILE
11.2.3 GINGKO
11.2.4 GINGER
11.2.5 VALERIAN
11.2.6 GARLIC
11.2.7 FEVERFEW
11.2.8 MILK THISTLE
11.2.9 GINSENG
11.2.10 SAW PALMETTO
11.2.11 OTHERS
11.3 MINERALS
11.3.1 NON-METALLIC MINERALS
11.3.1.1 CALCAREA CARBONICA (CALCIUM CARBONATE)
11.3.1.2 SILICEA(SILICA)
11.3.1.3 OTHERS
11.3.2 METALLIC MINERALS
11.3.2.1 AURUM METALLICUM(GOLD)
11.3.2.2 FERRUM METALLICUM(IRON)
11.3.2.3 OTHERS
11.4 ANIMALS
11.4.1 APIS MELLIFICA (HONEYBEE)
11.4.2 LACHESIS MUTA (BUSHMASTER SNAKE)
11.4.3 OTHERS
12 MEXICO HOMEOPATHY PRODUCTS MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 ANALGESIC AND ANTIPYRETIC
12.2.1 MUSCLES AND JOINT PAIN
12.2.2 SWELLING AND BRUISING
12.2.3 POST-SURGICAL PAIN
12.2.4 SPRAINS, STRAINS, AND MINOR TRAUMAS
12.2.5 OTHERS
12.3 RESPIRATORY DISEASES
12.3.1 UPPER RESPIRATORY TRACT INFECTIONS (URTIS)
12.3.2 ALLERGIC RHINITIS
12.3.3 ASTHMA
12.3.4 BRONCHITIS
12.3.5 SINUSITIS
12.3.6 COUGHS
12.3.7 OTHERS
12.4 IMMUNOLOGY DISORDERS
12.5 GASTROENTEROLOGY DISORDERS
12.5.1 DIGESTIVE DISCOMFORTS
12.5.2 DYSPEPSIA
12.5.3 BLOATING
12.5.4 CONSTIPATION
12.5.5 DIARRHEA
12.5.6 OTHERS
12.6 NEUROLOGY DISORDERS
12.6.1 MIGRAINES AND HEADACHES
12.6.2 NEUROPATHIC PAIN
12.6.3 RESTLESS LEG SYNDROME (RLS)
12.6.4 EPILEPSY
12.6.5 PARKINSON’S DISEASE
12.6.6 OTHERS
12.7 DERMATOLOGY DISORDERS
12.7.1 MINOR SKIN IRRITATIONS
12.7.2 INSECT BITES
12.7.3 MINOR SUNBURN
12.7.4 OTHERS
12.8 CNS (CENTRAL NERVOUS SYSTEM)
12.9 MENTAL HEALTH
12.9.1 ANXIETY
12.9.2 STRESS
12.9.3 INSOMNIA
12.9.4 DEPRESSION
12.9.5 OBSESSIVE-COMPULSIVE DISORDER (OCD)
12.9.6 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
12.9.7 OTHERS
12.1 HORMONAL DISEASES
12.10.1 PREMENSTRUAL SYNDROME
12.10.2 MENOPAUSAL VASOMOTOR SYMPTOMS
12.10.3 THYROID DISORDERS
12.10.4 OTHERS
12.11 SEXUAL WELLNESS
12.11.1 ERECTILE DYSFUNCTION (ED)
12.11.2 FEMALE SEXUAL DYSFUNCTION
12.11.3 3 INFERTILITY
12.11.4 OTHERS
12.12 OBESITY
12.13 OPHTHALMIC DISEASES
12.13.1 CONJUNCTIVITIS
12.13.2 DRY EYES
12.13.3 RED EYES
12.13.4 EYESTRAIN
12.13.5 UVEITIS
12.13.6 RETINAL DISORDERS
12.13.7 CORNEAL DISEASES
12.13.8 CROSS EYES (STRABISMUS)
12.13.9 NYSTAGMUS
12.13.10 OTHERS
12.14 OTHERS
13 MEXICO HOMEOPATHY PRODUCTS MARKET, BY MODE OF PURCHASE
13.1 OVERVIEW
13.2 OVER THE COUNTER (OTC)
13.3 PRESCRIPTION-BASED
14 MEXICO HOMEOPATHY PRODUCTS MARKET, BY ROUTE OF ADMINISTRATION
14.1 OVERVIEW
14.2 ORAL PRODUCTS
14.2.1 BY SOURCE
14.2.1.1 PLANTS
14.2.1.1.1 CANNABIS
14.2.1.1.2 CHAMOMILE
14.2.1.1.3 GINGKO
14.2.1.1.4 GINGER
14.2.1.1.5 VALERIAN
14.2.1.1.6 GARLIC
14.2.1.1.7 FEVERFEW
14.2.1.1.8 MILK THISTLE
14.2.1.1.9 GINSENG
14.2.1.1.10 SAW PALMETTO
14.2.1.1.11 OTHERS
14.2.1.2 MINERALS
14.2.1.2.1 NON-METALLIC MINERALS
14.2.1.2.1.1 CALCAREA CARBONICA (CALCIUM CARBONATE)
14.2.1.2.1.2 SILICEA(SILICA)
14.2.1.2.1.3 OTHERS
14.2.1.2.2 METALLIC MINERALS
14.2.1.2.2.1 AURUM METALLICUM (GOLD)
14.2.1.2.2.2 FERRUM METALLICUM (IRON)
14.2.1.2.2.3 OTHERS
14.2.1.3 ANIMALS
14.2.1.3.1 APIS MELLIFICA (HONEYBEE)
14.2.1.3.2 LACHESIS MUTA (BUSHMASTER SNAKE)
14.2.1.3.3 OTHERS
14.3 TOPICAL PRODUCTS
14.3.1 BY SOURCE
14.3.1.1 PLANTS
14.3.1.1.1 CANNABIS
14.3.1.1.2 CHAMOMILE
14.3.1.1.3 GINGKO
14.3.1.1.4 GINGER
14.3.1.1.5 VALERIAN
14.3.1.1.6 GARLIC
14.3.1.1.7 FEVERFEW
14.3.1.1.8 MILK THISTLE
14.3.1.1.9 GINSENG
14.3.1.1.10 SAW PALMETTO
14.3.1.1.11 OTHERS
14.3.1.2 MINERALS
14.3.1.2.1 NON-METALLIC MINERALS
14.3.1.2.1.1 CALCAREA CARBONICA (CALCIUM CARBONATE)
14.3.1.2.1.2 SILICEA (SILICA)
14.3.1.2.1.3 OTHERS
14.3.1.2.2 METALLIC MINERALS
14.3.1.2.2.1 AURUM METALLICUM (GOLD)
14.3.1.2.2.2 FERRUM METALLICUM (IRON)
14.3.1.2.2.3 OTHERS
14.3.1.3 ANIMALS
14.3.1.3.1 APIS MELLIFICA (HONEYBEE)
14.3.1.3.2 LACHESIS MUTA (BUSHMASTER SNAKE)
14.3.1.3.3 OTHERS
14.4 OTHERS
15 MEXICO HOMEOPATHY PRODUCTS MARKET, BY END USER
15.1 OVERVIEW
15.2 HOMEOPATHY CENTERS
15.3 CLINICS
15.4 HOSPITAL
15.4.1 PUBLIC HOSPITALS
15.4.2 PRIVATE HOSPITALS
15.5 HOMECARE
15.6 OTHERS
16 MEXICO HOMEOPATHY PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 RETAIL SALES
16.2.1 RETAIL PHARMACY
16.2.2 ONLINE PHARMACY
16.2.3 HOSPITAL PHARMACY
16.3 DIRECT TENDER
16.4 OTHERS
17 MEXICO HOMEOPATHY PRODUCTS MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: MEXICO
18 SWOT ANALYSIS
19 COMPANY PROFILES
19.1 SCHWABE MÉXICO, S.A. DE C.V. (DR. WILLMAR SCHWABE GMBH & CO. KG)
19.1.1 COMPANY SNAPSHOT
19.1.2 PRODUCT PORTFOLIO
19.1.3 RECENT DEVELOPMENTS
19.2 BIOLOGISCHE HEILMITTEL HEEL GMBH
19.2.1 COMPANY SNAPSHOT
19.2.2 PRODUCT PORTFOLIO
19.2.3 RECENT DEVELOPMENT
19.3 NARTEX LABS
19.3.1 COMPANY SNAPSHOT
19.3.2 PRODUCT PORTFOLIO
19.3.3 RECENT DEVELOPMENT
19.4 AF OPERADORA DE NEGOCIOS S.A. DE C.V.
19.4.1 COMPANY SNAPSHOT
19.4.2 PRODUCT PORTFOLIO
19.4.3 RECENT DEVELOPMENT
19.5 NATURAL AND ORGANIC FARMS MÉXICO, S.A. DE C.V.
19.5.1 COMPANY SNAPSHOT
19.5.2 PRODUCT PORTFOLIO
19.5.3 RECENT DEVELOPMENT
19.6 BOTANIC HEALTHCARE.
19.6.1 COMPANY SNAPSHOT
19.6.2 PRODUCT PORTFOLIO
19.6.3 RECENT DEVELOPMENT
19.7 DR. RECKEWEG & CO. GMBH
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 HÄSLER HOMEOPATHIC LABORATORIES
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT DEVELOPMENT
19.9 SIMILIA
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENT
19.1 SINERGIA FARMACÉUTICA SAPI DE CV (BIOFARMA NATURAL CMD SA DE CV)
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
表格列表
TABLE 1 MEXICO HOMEOPATHY PRODUCTS MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 MEXICO DILUTIONS IN HOMEOPATHY PRODUCTS MARKET, BY POTENCY, 2018-2032 (USD THOUSAND)
TABLE 3 MEXICO HIGH POTENCY IN HOMEOPATHY PRODUCTS MARKET, BY POTENCY, 2018-2032 (USD THOUSAND)
TABLE 4 MEXICO MEDIUM POTENCY IN HOMEOPATHY PRODUCTS MARKET, BY POTENCY, 2018-2032 (USD THOUSAND)
TABLE 5 MEXICO LOW POTENCY IN HOMEOPATHY PRODUCTS MARKET, BY POTENCY, 2018-2032 (USD THOUSAND)
TABLE 6 MEXICO DILUTIONS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 7 MEXICO PLANTS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 8 MEXICO MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 9 MEXICO NON-METALLIC MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 10 MEXICO METALLIC MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 11 MEXICO ANIMALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 12 MEXICO TABLETS IN HOMEOPATHY PRODUCTS MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 13 MEXICO TINCTURE IN HOMEOPATHY PRODUCTS MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 14 MEXICO TINCTURE IN HOMEOPATHY PRODUCTS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 MEXICO TINCTURE IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 16 MEXICO PLANTS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 17 MEXICO OINTMENTS IN HOMEOPATHY PRODUCTS MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 18 MEXICO OINTMENTS IN HOMEOPATHY PRODUCTS MARKET, BY USAGE, 2018-2032 (USD THOUSAND)
TABLE 19 MEXICO TOPICAL PAIN RELIEF IN HOMEOPATHY PRODUCTS MARKET, BY USAGE, 2018-2032 (USD THOUSAND)
TABLE 20 MEXICO SKIN CONDITIONS IN HOMEOPATHY PRODUCTS MARKET, BY USAGE, 2018-2032 (USD THOUSAND)
TABLE 21 MEXICO BIOCHEMICS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 22 MEXICO OILS IN HOMEOPATHY PRODUCTS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 MEXICO HOMEOPATHY PRODUCTS MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)
TABLE 24 MEXICO HOMEOPATHY PRODUCTS MARKET, BY GENDER, 2018-2032 (USD THOUSAND)
TABLE 25 MEXICO HOMEOPATHY PRODUCTS MARKET, BY TREATMENT, 2018-2032 (USD THOUSAND)
TABLE 26 MEXICO HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 27 MEXICO PLANTS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 28 MEXICO MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 29 MEXICO NON-METALLIC MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 30 MEXICO METALLIC MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 31 MEXICO ANIMALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 32 MEXICO HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 33 MEXICO ANALGESIC AND ANTIPYRETIC IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 34 MEXICO RESPIRATORY DISEASES IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 35 MEXICO GASTROENTEROLOGY DISORDERS IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 36 MEXICO NEUROLOGY DISORDERS IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 37 MEXICO DERMATOLOGY DISORDERS IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 38 MEXICO MENTAL HEALTH IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 39 MEXICO HORMONAL DISEASES IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 40 MEXICO SEXUAL WELLNESS IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 41 MEXICO OPHTHALMIC DISEASES IN HOMEOPATHY PRODUCTS MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 42 MEXICO HOMEOPATHY PRODUCTS MARKET, BY MODE OF PURCHASE, 2018-2032 (USD THOUSAND)
TABLE 43 MEXICO HOMEOPATHY PRODUCTS MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD THOUSAND)
TABLE 44 MEXICO ORAL PRODUCTS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 45 MEXICO PLANTS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 46 MEXICO MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 47 MEXICO NON-METALLIC MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 48 MEXICO METALLIC MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 49 MEXICO ANIMALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 50 MEXICO TOPICAL PRODUCTS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 51 MEXICO PLANTS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 52 MEXICO MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 53 MEXICO NON-METALLIC MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 54 MEXICO METALLIC MINERALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 55 MEXICO ANIMALS IN HOMEOPATHY PRODUCTS MARKET, BY SOURCE, 2018-2032 (USD THOUSAND)
TABLE 56 MEXICO HOMEOPATHY PRODUCTS MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 57 MEXICO HOSPITAL IN HOMEOPATHY PRODUCTS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 58 MEXICO HOMEOPATHY PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 59 MEXICO RETAIL SALES IN HOMEOPATHY PRODUCTS MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
图片列表
FIGURE 1 MEXICO HOMEOPATHY PRODUCTS MARKET: SEGMENTATION
FIGURE 2 MEXICO HOMEOPATHY PRODUCTS MARKET: DATA TRIANGULATION
FIGURE 3 MEXICO HOMEOPATHY PRODUCTS MARKET: DROC ANALYSIS
FIGURE 4 MEXICO HOMEOPATHY PRODUCTS MARKET: COUNTRY-WISE MARKET ANALYSIS
FIGURE 5 MEXICO HOMEOPATHY PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MEXICO HOMEOPATHY PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MEXICO HOMEOPATHY PRODUCTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MEXICO HOMEOPATHY PRODUCTS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 MEXICO HOMEOPATHY PRODUCTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MEXICO HOMEOPATHY PRODUCTS MARKET: SEGMENTATION
FIGURE 11 MEXICO HOMEOPATHY PRODUCTS MARKET: EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 SEVEN SEGMENTS COMPRISE THE MEXICO HOMEOPATHY PRODUCTS MARKET, BY PRODUCT TYPE (2024)
FIGURE 14 INCREASING CONSUMER AWARENESS OF NATURAL HEALTH SOLUTIONS IS EXPECTED TO DRIVE THE MEXICO HOMEOPATHY PRODUCTS MARKET FROM 2025 TO 2032
FIGURE 15 THE DILUTIONS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MEXICO HOMEOPATHY PRODUCTS MARKET IN 2025 AND 2032
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MEXICO HOMEOPATHY PRODUCTS MARKET
FIGURE 17 MEXICO HOMEOPATHY PRODUCTS MARKET: BY PRODUCT TYPE, 2024
FIGURE 18 MEXICO HOMEOPATHY PRODUCTS MARKET: BY PRODUCT TYPE, 2025 TO 2032 (USD THOUSAND)
FIGURE 19 MEXICO HOMEOPATHY PRODUCTS MARKET: BY PRODUCT TYPE, CAGR (2025-2032)
FIGURE 20 MEXICO HOMEOPATHY PRODUCTS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 MEXICO HOMEOPATHY PRODUCTS MARKET: BY AGE GROUP, 2024
FIGURE 22 MEXICO HOMEOPATHY PRODUCTS MARKET: BY AGE GROUP, 2025 TO 2032 (USD THOUSAND)
FIGURE 23 MEXICO HOMEOPATHY PRODUCTS MARKET: BY AGE GROUP, CAGR (2025-2032)
FIGURE 24 MEXICO HOMEOPATHY PRODUCTS MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 25 MEXICO HOMEOPATHY PRODUCTS MARKET: BY GENDER, 2024
FIGURE 26 MEXICO HOMEOPATHY PRODUCTS MARKET: BY GENDER, 2025 TO 2032 (USD THOUSAND)
FIGURE 27 MEXICO HOMEOPATHY PRODUCTS MARKET: BY GENDER, CAGR (2025-2032)
FIGURE 28 MEXICO HOMEOPATHY PRODUCTS MARKET: BY GENDER, LIFELINE CURVE
FIGURE 29 MEXICO HOMEOPATHY PRODUCTS MARKET: BY TREATMENT, 2024
FIGURE 30 MEXICO HOMEOPATHY PRODUCTS MARKET: BY TREATMENT, 2025 TO 2032 (USD THOUSAND)
FIGURE 31 MEXICO HOMEOPATHY PRODUCTS MARKET: BY TREATMENT, CAGR (2025-2032)
FIGURE 32 MEXICO HOMEOPATHY PRODUCTS MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 33 MEXICO HOMEOPATHY PRODUCTS MARKET: BY SOURCE, 2024
FIGURE 34 MEXICO HOMEOPATHY PRODUCTS MARKET: BY SOURCE, 2025 TO 2032 (USD THOUSAND)
FIGURE 35 MEXICO HOMEOPATHY PRODUCTS MARKET: BY SOURCE, CAGR (2025-2032)
FIGURE 36 MEXICO HOMEOPATHY PRODUCTS MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 37 MEXICO HOMEOPATHY PRODUCTS MARKET: BY APPLICATION, 2024
FIGURE 38 MEXICO HOMEOPATHY PRODUCTS MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 39 MEXICO HOMEOPATHY PRODUCTS MARKET: BY APPLICATION, CAGR (2025-2032)
FIGURE 40 MEXICO HOMEOPATHY PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 41 MEXICO HOMEOPATHY PRODUCTS MARKET: BY MODE OF PURCHASE, 2024
FIGURE 42 MEXICO HOMEOPATHY PRODUCTS MARKET: BY MODE OF PURCHASE, 2025 TO 2032 (USD THOUSAND)
FIGURE 43 MEXICO HOMEOPATHY PRODUCTS MARKET: BY MODE OF PURCHASE, CAGR (2025-2032)
FIGURE 44 MEXICO HOMEOPATHY PRODUCTS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 45 MEXICO HOMEOPATHY PRODUCTS MARKET: BY ROUTE OF ADMINISTRATION, 2024
FIGURE 46 MEXICO HOMEOPATHY PRODUCTS MARKET: BY ROUTE OF ADMINISTRATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 47 MEXICO HOMEOPATHY PRODUCTS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2025-2032)
FIGURE 48 MEXICO HOMEOPATHY PRODUCTS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 49 MEXICO HOMEOPATHY PRODUCTS MARKET: BY END USER, 2024
FIGURE 50 MEXICO HOMEOPATHY PRODUCTS MARKET: BY END USER, 2025 TO 2032 (USD THOUSAND)
FIGURE 51 MEXICO HOMEOPATHY PRODUCTS MARKET: BY END USER, CAGR (2025-2032)
FIGURE 52 MEXICO HOMEOPATHY PRODUCTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 53 MEXICO HOMEOPATHY PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2024
FIGURE 54 MEXICO HOMEOPATHY PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2032 (USD THOUSAND)
FIGURE 55 MEXICO HOMEOPATHY PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 56 MEXICO HOMEOPATHY PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 57 MEXICO HOMEOPATHY PRODUCTS MARKET: COMPANY SHARE 2024 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
